Cibus (CBUS) Projected to Post Quarterly Earnings on Thursday

Cibus (NASDAQ:CBUS) will likely be posting its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect Cibus to post earnings of ($0.68) per share and revenue of $1.13 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Cibus Trading Down 3.4 %

Cibus stock opened at $2.30 on Wednesday. Cibus has a 12-month low of $1.80 and a 12-month high of $23.18. The stock has a market cap of $60.85 million, a P/E ratio of -0.10 and a beta of 2.04. The company has a 50-day moving average price of $2.35 and a 200 day moving average price of $3.40.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reduced their price target on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Wednesday, January 22nd.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cibus stock. Bank of America Corp DE raised its holdings in Cibus, Inc. (NASDAQ:CBUS) by 113.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,536 shares of the company’s stock after buying an additional 18,885 shares during the period. Bank of America Corp DE owned approximately 0.13% of Cibus worth $99,000 as of its most recent SEC filing. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.